Siga este enlace para ver otros tipos de publicaciones sobre el tema: Interleukin-12.

Artículos de revistas sobre el tema "Interleukin-12"

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Interleukin-12".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.

1

Leonard, Patricia, and Sanjiv Sur. "Interleukin-12." BioDrugs 17, no. 1 (2003): 1–7. http://dx.doi.org/10.2165/00063030-200317010-00001.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

&NA;. "Interleukin-12." Inpharma Weekly &NA;, no. 1124 (1998): 7. http://dx.doi.org/10.2165/00128413-199811240-00013.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Trinchieri, Giorgio. "Interleukin-12." Clinical Immunotherapeutics 3, no. 4 (1995): 262–70. http://dx.doi.org/10.1007/bf03259278.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Clinton, Steven K., Eduardo Canto, and Michael A. O'Donnell. "INTERLEUKIN-12." Urologic Clinics of North America 27, no. 1 (2000): 147–55. http://dx.doi.org/10.1016/s0094-0143(05)70242-1.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Weiner, David. "Plasmid Interleukin 12." AIDS 14, no. 12 (2000): 1759–60. http://dx.doi.org/10.1097/00002030-200008180-00010.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Leng, S. X., and J. A. Elias. "Interleukin-11 inhibits macrophage interleukin-12 production." Journal of Immunology 159, no. 5 (1997): 2161–68. http://dx.doi.org/10.4049/jimmunol.159.5.2161.

Texto completo
Resumen
Abstract IL-12 is a heterodimeric cytokine produced by phagocytic and other cells with important physiologic and pathologic properties. Regulated IL-12 production is crucial for the generation of protective Th1 responses to infectious agents. In contrast, IL-12 excess contributes to the pathogenesis of a variety of autoimmune and inflammatory disorders. To further understand the processes regulating IL-12 production, we determined whether IL-11 regulated monocyte/macrophage production of this cytokine moiety. IL-11 did not alter the IL-12 (p70) production of unstimulated THP-1 monocytic cells
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Fox, Robert J., and Abdolmohamad M. Rostami. "Anti???Interleukin-12 Antibody." BioDrugs 13, no. 4 (2000): 233–41. http://dx.doi.org/10.2165/00063030-200013040-00002.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

&NA;. "Interleukin-12 trial halted." Reactions Weekly &NA;, no. 556 (1995): 2. http://dx.doi.org/10.2165/00128415-199505560-00003.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

&NA;. "Interleukin-12 studies continue." Reactions Weekly &NA;, no. 558 (1995): 2. http://dx.doi.org/10.2165/00128415-199505580-00003.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

&NA;. "Interleukin-12 trial halted." Inpharma Weekly &NA;, no. 992 (1995): 21. http://dx.doi.org/10.2165/00128413-199509920-00047.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
11

&NA;. "Interleukin-12 studies continue." Inpharma Weekly &NA;, no. 994 (1995): 21. http://dx.doi.org/10.2165/00128413-199509940-00042.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
12

KATIYAR, S. "Interleukin-12 and photocarcinogenesis." Toxicology and Applied Pharmacology 224, no. 3 (2007): 220–27. http://dx.doi.org/10.1016/j.taap.2006.11.017.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
13

Maguire, H. C. "INTERLEUKIN 12 AS IMMUNOADJUVANT." Journal of Immunotherapy 16, no. 3 (1994): 240. http://dx.doi.org/10.1097/00002371-199410000-00032.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
14

de Rie, M. A. "Interleukin 12 and Psoriasis." Dermatology 199, no. 2 (1999): 101. http://dx.doi.org/10.1159/000018213.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
15

Trinchieri, Giorgio, and Franca Gerosa. "Immunoregulation by interleukin-12." Journal of Leukocyte Biology 59, no. 4 (1996): 505–11. http://dx.doi.org/10.1002/jlb.59.4.505.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
16

Ma, X., A. D'Andrea, M. Kubin, et al. "Production of interleukin-12." Research in Immunology 146, no. 7-8 (1995): 432–38. http://dx.doi.org/10.1016/0923-2494(96)83012-4.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
17

Crutcher, J. M., M. M. Stevenson, M. Sedegah, and S. L. Hoffman. "Interleukin-12 and malaria." Research in Immunology 146, no. 7-8 (1995): 552–59. http://dx.doi.org/10.1016/0923-2494(96)83031-8.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
18

Tsai, I. San, Chi-Cheng Tsai, Ya-Ping Ho, Kun-Yen Ho, Yi-Min Wu, and Chun-Cheng Hung. "Interleukin-12 and interleukin-16 in periodontal disease." Cytokine 31, no. 1 (2005): 34–40. http://dx.doi.org/10.1016/j.cyto.2005.02.007.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
19

BACON, CHRIS M., SARAH S. CHO, and JOHN J. O'SHEA. "Signal Transduction by Interleukin-12 and Interleukin-2." Annals of the New York Academy of Sciences 795, no. 1 Interleukin 1 (1996): 41–59. http://dx.doi.org/10.1111/j.1749-6632.1996.tb52654.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
20

Torti, Dorothea C., and Steven R. Feldman. "Interleukin-12, interleukin-23, and psoriasis: Current prospects." Journal of the American Academy of Dermatology 57, no. 6 (2007): 1059–68. http://dx.doi.org/10.1016/j.jaad.2007.07.016.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
21

Sánchez, E., S. Morales, L. Paco, et al. "Interleukin 12 (IL12B), interleukin 12 receptor (IL12RB1) and interleukin 23 (IL23A) gene polymorphism in systemic lupus erythematosus." Rheumatology 44, no. 9 (2005): 1136–39. http://dx.doi.org/10.1093/rheumatology/keh697.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
22

Orozco, Gisela, Miguel A. González-Gay, Laura Paco, et al. "Interleukin 12 (IL12B) and Interleukin 12 Receptor (IL12RB1) Gene Polymorphisms in Rheumatoid Arthritis." Human Immunology 66, no. 6 (2005): 710–14. http://dx.doi.org/10.1016/j.humimm.2005.02.004.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
23

Mattner, Frank, Susanne Fischer, Stefanie Guckes, et al. "The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer." European Journal of Immunology 23, no. 9 (1993): 2202–8. http://dx.doi.org/10.1002/eji.1830230923.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
24

Eman, Arif Rahman, Vitayani Muchtar Sri, Tabri Farida, et al. "EVALUATION OF INTERLEUKIN-12 AND INTERLEUKIN-4 LEVELS IN MULTIBACILLARY-TYPE LEPROSY PATIENT 12 MONTHS AFTER RIFAMPICIN OFLOXACIN MINOCYCLINE COMBINATION THERAPY." International Journal of Medical Reviews and Case Reports 2, no. 4 (2018): 161–65. https://doi.org/10.5455/IJMRCR.MULTIBACILLARY-TYPE-LEPROSY-INTERLEUKINS.

Texto completo
Resumen
Background: Leprosy is a chronic infectious disease caused by Mycobacterium leprae. In leprosy, cell-mediated immune responses are an important aspect of host resistance to mycobacterial infections and allegedly governed by anequilibrium between type 1 cytokines including Interleukin-12 (IL-12); with type 2 cytokines such as Interleukin-4 (IL-4). Currently, the World Health Organization (WHO) recommends 3 leprosy treatment regimens, one of them is Rifampicin Ofloxacin Minocycline (ROM). To date, studies on the effects of ROM on leprosy have been limited, none have specifically assessed the eff
Los estilos APA, Harvard, Vancouver, ISO, etc.
25

Lu, Zhiyu, Keye Xu, Xiaoying Wang, Yan Li, and Mingcai Li. "Interleukin 39: a new member of interleukin 12 family." Central European Journal of Immunology 45, no. 2 (2020): 214–17. http://dx.doi.org/10.5114/ceji.2020.97911.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
26

Rentzos, M., C. Nikolaou, E. Andreadou, et al. "Circulating interleukin-10 and interleukin-12 in Parkinson’s disease." Acta Neurologica Scandinavica 119, no. 5 (2009): 332–37. http://dx.doi.org/10.1111/j.1600-0404.2008.01103.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
27

Tahara, H., L. Zitvogel, W. J. Storkus, T. G. McKinney, P. D. Robbins, and M. T. Lotze. "CANCER GENE THERAPY USING INTERLEUKIN-12 (IL-12)." Journal of Immunotherapy 16, no. 3 (1994): 245. http://dx.doi.org/10.1097/00002371-199410000-00053.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
28

&NA;. "Interleukin-12 toxicity mystery solved." Reactions Weekly &NA;, no. 580 (1995): 2. http://dx.doi.org/10.2165/00128415-199505800-00002.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
29

&NA;. "Interleukin-12 toxicity mystery solved." Inpharma Weekly &NA;, no. 1016 (1995): 21. http://dx.doi.org/10.2165/00128413-199510160-00046.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
30

Romani, L., P. Puccetti, and F. Bistoni. "Interleukin-12 in infectious diseases." Clinical Microbiology Reviews 10, no. 4 (1997): 611–36. http://dx.doi.org/10.1128/cmr.10.4.611.

Texto completo
Resumen
Interleukin-12 (IL-12) is a potent immunoregulatory cytokine that is crucially involved in a wide range of infectious diseases. In several experimental models of bacterial, parasitic, viral, and fungal infection, endogenous IL-12 is required for early control of infection and for generation and perhaps maintenance of acquired protective immunity, directed by T helper type 1 (Th1) cells and mediated by phagocytes. Although the relative roles of IL-12 and gamma interferon in Th1-cell priming may be to a significant extent pathogen dependent, common to most infections is that IL-12 regulates the
Los estilos APA, Harvard, Vancouver, ISO, etc.
31

Romani, L., P. Puccetti, and F. Bistoni. "Interleukin-12 in infectious diseases." Clinical microbiology reviews 10, no. 4 (1997): 611–36. http://dx.doi.org/10.1128/cmr.10.4.611-636.1997.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
32

Bashyam, Hema. "Interleukin-12: A master regulator." Journal of Experimental Medicine 204, no. 5 (2007): 969. http://dx.doi.org/10.1084/jem.2045fta.

Texto completo
Resumen
Early resistance to pathogens requires a swift response from NK cells. In 1989, Giorgio Trinchieri identified an NK growth factor and activator, later called interleukin-12 (IL-12). This discovery helped reveal the regulatory link between innate and adaptive immunity.
Los estilos APA, Harvard, Vancouver, ISO, etc.
33

Adorini, Luciano. "Interleukin 12 and autoimmune diabetes." Nature Genetics 27, no. 2 (2001): 131–32. http://dx.doi.org/10.1038/84732.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
34

Bubeník, Jan. "Interleukin 12 in Cancer Treatment." Folia Biologica 57, no. 1 (2011): 1–2. http://dx.doi.org/10.14712/fb2011057010001.

Texto completo
Resumen
Interleukin 12 (IL-12) is made up of two disulphidelinked chains, p35 and p40. The cytokine is produced by monocytes, macrophages, myeloid dendritic cells and B cells. It stimulates development of NK cells and TH1 differentiation of CD4+ T cells, thus participating in the regulation of the immune response (for a review, see Klein and Hořejší, 1997; Grufman and Kärre, 2000; Jinushi and Tahara, 2009). Recently, the structurally similar but functionally different cytokine IL-23 displaying anti-tumour effects and related to the IL-12 family of cytokines was discovered (Engel and Neurath, 2010). In
Los estilos APA, Harvard, Vancouver, ISO, etc.
35

Sacks, G. P., D. Scott, H. Tivnann, T. Mire-Sluis, I. L. Sargent, and C. W. G. Redman. "Interleukin-12 and pre-eclampsia." Journal of Reproductive Immunology 34, no. 2 (1997): 155–58. http://dx.doi.org/10.1016/s0165-0378(97)00028-4.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
36

Bryan, Dani-Louise, Joanna S. Hawkes, and Robert A. Gibson. "Interleukin-12 in Human Milk." Pediatric Research 45, no. 6 (1999): 858–59. http://dx.doi.org/10.1203/00006450-199906000-00013.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
37

Sturmhoefel, K., K. Lee, M. O. Toole, H. M. Swiniarski, A. J. Dorner, and S. F. Wolf(xc*). "Interleukin 12 as vaccine adjuvant." Research in Immunology 149, no. 1 (1998): 37–39. http://dx.doi.org/10.1016/s0923-2494(98)80041-2.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
38

Rowe, PaulM. "Cautious optimism over interleukin-12." Lancet 345, no. 8962 (1995): 1432. http://dx.doi.org/10.1016/s0140-6736(95)92618-6.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
39

Trinchieri, Giorgio, Manthrasalam Rengaraju, Annalisa D'Andrea, et al. "Producer cells of interleukin-12." Immunology Today 14, no. 5 (1993): 237–38. http://dx.doi.org/10.1016/0167-5699(93)90173-i.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
40

MA, XIAOJING, MIGUEL ASTE-AMEZAGA, and GIORGIO TRINCHIERI. "Regulation of Interleukin-12 Production." Annals of the New York Academy of Sciences 795, no. 1 Interleukin 1 (1996): 13–25. http://dx.doi.org/10.1111/j.1749-6632.1996.tb52651.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
41

BLISS, JUDY, RICHARD MAYLOR, KEYA STOKES, KRISTIN S. MURRAY, MARA A. KETCHUM, and STANLEY F. WOLF. "Interleukin-12 as Vaccine Adjuvant." Annals of the New York Academy of Sciences 795, no. 1 Interleukin 1 (1996): 26–35. http://dx.doi.org/10.1111/j.1749-6632.1996.tb52652.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
42

Podlaski, Frank J., Venkata B. Nanduri, Jeffrey D. Hulmes, et al. "Molecular characterization of interleukin 12." Archives of Biochemistry and Biophysics 294, no. 1 (1992): 230–37. http://dx.doi.org/10.1016/0003-9861(92)90162-p.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
43

Trinchieri, Giorgio, Manthrasalam Rengaraju, Annalisa D'Andrea, et al. "Producer cells of interleukin 12." Parasitology Today 9, no. 3 (1993): 97. http://dx.doi.org/10.1016/0169-4758(93)90215-2.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
44

Brunda, Michael J., and Maurice K. Gately. "Antitumor Activity of Interleukin-12." Clinical Immunology and Immunopathology 71, no. 3 (1994): 253–55. http://dx.doi.org/10.1006/clin.1994.1081.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
45

Karp, Christopher L. "Interleukin-12: Amiss in MS." Annals of Neurology 45, no. 6 (1999): 689–92. http://dx.doi.org/10.1002/1531-8249(199906)45:6<689::aid-ana1>3.0.co;2-m.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
46

Gately, Maurice K., Louis M. Renzetti, Jeanne Magram, et al. "THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune Responses." Annual Review of Immunology 16, no. 1 (1998): 495–521. http://dx.doi.org/10.1146/annurev.immunol.16.1.495.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
47

Wang, Xin, Victoria L. Wilkinson, Frank J. Podlaski, et al. "Characterization of mouse interleukin-12 p40 homodimer binding to the interleukin-12 receptor subunits." European Journal of Immunology 29, no. 6 (1999): 2007–13. http://dx.doi.org/10.1002/(sici)1521-4141(199906)29:06<2007::aid-immu2007>3.0.co;2-0.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
48

Yücel, Özlem Özer, Ezel Berker, Semra Gariboğlu та Harika Otlu. "Interleukin-11, interleukin-1β, interleukin-12 and the pathogenesis of inflammatory periodontal diseases". Journal of Clinical Periodontology 35, № 5 (2008): 365–70. http://dx.doi.org/10.1111/j.1600-051x.2008.01212.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
49

GATELY, MAURICE K., DAISY M. CARVAJAL, SUZANNE E. CONNAUGHTON, et al. "Interleukin-12 Antagonist Activity of Mouse Interleukin-12 p40 Homodimer in Vitro and in Vivo." Annals of the New York Academy of Sciences 795, no. 1 Interleukin 1 (1996): 1–12. http://dx.doi.org/10.1111/j.1749-6632.1996.tb52650.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
50

Robinson, Cory M., and Gerard J. Nau. "Interleukin‐12 and Interleukin‐27 Regulate Macrophage Control ofMycobacterium tuberculosis." Journal of Infectious Diseases 198, no. 3 (2008): 359–66. http://dx.doi.org/10.1086/589774.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!